Skip to main content
Erschienen in: Journal of Neural Transmission 12/2009

01.12.2009 | Basic Neurosciences, Genetics and Immunology - Original Article

Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons

verfasst von: Ting-Ting Yang, Chao-Tien Hsu, Yu-Min Kuo

Erschienen in: Journal of Neural Transmission | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

The concentrations of soluble β-amyloid (Aβ) oligomers paralleled with the extent of synaptic loss and severity of cognitive impairment in Alzheimer patients. However, the neurotoxicity of the naturally generated Aβ species remains unknown. This study was designed to examine the effects of naturally generated Aβ oligomers, secreted from amyloid precursor protein-expressing cells, on the homeostasis and viability of primary hippocampal neurons. Our results showed that primary hippocampal neurons incubated with condition media containing cell-secreted soluble Aβ had higher levels of heat-shock protein (HSP)27, HSP60 and HSP70, and lower levels of HSP32 than those of the control neurons. The cell-secreted soluble Aβ caused mitochondria dysfunction in hippocampal neurons as demonstrated by depolarized membrane potential and decreased cytochrome c oxidase activity and ATP levels. The levels of pro-apoptotic proteins, Bid, Bax and cytochrome C, were elevated; whereas anti-apoptotic Bcl-2 protein was reduced in the soluble Aβ-cultured neurons. Apoptosis was also evident in these soluble Aβ-cultured neurons. These results indicate that naturally secreted Aβ induces neuronal injury/death by activating an apoptotic pathway involving impaired mitochondria function and cellular homeostasis.
Literatur
Zurück zum Zitat Anandatheerthavarada HK, Biswas G, Robin MA et al (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer’s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41–54CrossRefPubMed Anandatheerthavarada HK, Biswas G, Robin MA et al (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer’s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41–54CrossRefPubMed
Zurück zum Zitat Clarimon J, Bertranpetit J, Boada M et al (2003) HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer’s disease. J Geriatr Psychiatry Neurol 16:146–150CrossRefPubMed Clarimon J, Bertranpetit J, Boada M et al (2003) HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer’s disease. J Geriatr Psychiatry Neurol 16:146–150CrossRefPubMed
Zurück zum Zitat Cleary JP, Walsh DM, Hofmeister JJ et al (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79–84CrossRefPubMed Cleary JP, Walsh DM, Hofmeister JJ et al (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79–84CrossRefPubMed
Zurück zum Zitat Clementi ME, Marini S, Coletta M et al (2005) Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett 579:2913–2918CrossRefPubMed Clementi ME, Marini S, Coletta M et al (2005) Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett 579:2913–2918CrossRefPubMed
Zurück zum Zitat Converso DP, Taille C, Carreras MC et al (2006) HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. Faseb J 20:1236–1238CrossRefPubMed Converso DP, Taille C, Carreras MC et al (2006) HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. Faseb J 20:1236–1238CrossRefPubMed
Zurück zum Zitat Evans CG, Wisen S, Gestwicki JE (2006) Heat-shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem 281:33182–33191CrossRefPubMed Evans CG, Wisen S, Gestwicki JE (2006) Heat-shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem 281:33182–33191CrossRefPubMed
Zurück zum Zitat Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185CrossRefPubMed Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185CrossRefPubMed
Zurück zum Zitat Hartley DM, Walsh DM, Ye CP et al (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876–8884PubMed Hartley DM, Walsh DM, Ye CP et al (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876–8884PubMed
Zurück zum Zitat Katzman R, Terry R, DeTeresa R et al (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144CrossRefPubMed Katzman R, Terry R, DeTeresa R et al (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144CrossRefPubMed
Zurück zum Zitat Kayed R, Head E, Thompson JL et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486–489CrossRefPubMed Kayed R, Head E, Thompson JL et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486–489CrossRefPubMed
Zurück zum Zitat Kuo YM, Emmerling MR, Vigo-Pelfrey C et al (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077–4081CrossRefPubMed Kuo YM, Emmerling MR, Vigo-Pelfrey C et al (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077–4081CrossRefPubMed
Zurück zum Zitat Kuo YM, Emmerling MR, Woods AS et al (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem Biophys Res Commun 237:188–191CrossRefPubMed Kuo YM, Emmerling MR, Woods AS et al (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem Biophys Res Commun 237:188–191CrossRefPubMed
Zurück zum Zitat Kuo YM, Webster S, Emmerling MR et al (1998) Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer’s disease. Biochim Biophys Acta 1406:291–298PubMed Kuo YM, Webster S, Emmerling MR et al (1998) Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer’s disease. Biochim Biophys Acta 1406:291–298PubMed
Zurück zum Zitat Lambert MP, Barlow AK, Chromy BA et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453CrossRefPubMed Lambert MP, Barlow AK, Chromy BA et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453CrossRefPubMed
Zurück zum Zitat Liao L, Cheng D, Wang J et al (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem 279:37061–37068CrossRefPubMed Liao L, Cheng D, Wang J et al (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem 279:37061–37068CrossRefPubMed
Zurück zum Zitat Lue LF, Kuo YM, Roher AE et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155:853–862PubMed Lue LF, Kuo YM, Roher AE et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155:853–862PubMed
Zurück zum Zitat Maes OC, Kravitz S, Mawal Y et al (2006) Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis 24:89–100CrossRefPubMed Maes OC, Kravitz S, Mawal Y et al (2006) Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis 24:89–100CrossRefPubMed
Zurück zum Zitat Magrane J, Smith RC, Walsh K et al (2004) Heat-shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24:1700–1706CrossRefPubMed Magrane J, Smith RC, Walsh K et al (2004) Heat-shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24:1700–1706CrossRefPubMed
Zurück zum Zitat Masliah E, Honer WG, Mallory M et al (1994) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer’s disease hippocampus. Acta Neuropathol 87:135–142CrossRefPubMed Masliah E, Honer WG, Mallory M et al (1994) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer’s disease hippocampus. Acta Neuropathol 87:135–142CrossRefPubMed
Zurück zum Zitat McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866CrossRefPubMed McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866CrossRefPubMed
Zurück zum Zitat Mehta PD, Pirttila T, Mehta SP et al (2000) Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57:100–105CrossRefPubMed Mehta PD, Pirttila T, Mehta SP et al (2000) Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57:100–105CrossRefPubMed
Zurück zum Zitat Morishima-Kawashima M, Ihara Y (1998) The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37:15247–15253CrossRefPubMed Morishima-Kawashima M, Ihara Y (1998) The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37:15247–15253CrossRefPubMed
Zurück zum Zitat Motter R, Vigo-Pelfrey C, Kholodenko D et al (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol 38:643–648CrossRefPubMed Motter R, Vigo-Pelfrey C, Kholodenko D et al (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol 38:643–648CrossRefPubMed
Zurück zum Zitat Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11–22CrossRefPubMed Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11–22CrossRefPubMed
Zurück zum Zitat Naslund J, Haroutunian V, Mohs R et al (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571–1577CrossRefPubMed Naslund J, Haroutunian V, Mohs R et al (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571–1577CrossRefPubMed
Zurück zum Zitat Nunomura A, Perry G, Aliev G et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759–767PubMed Nunomura A, Perry G, Aliev G et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759–767PubMed
Zurück zum Zitat Pillot T, Drouet B, Queille S et al (1999) The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J Neurochem 73:1626–1634CrossRefPubMed Pillot T, Drouet B, Queille S et al (1999) The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J Neurochem 73:1626–1634CrossRefPubMed
Zurück zum Zitat Podlisny MB, Ostaszewski BL, Squazzo SL et al (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270:9564–9570CrossRefPubMed Podlisny MB, Ostaszewski BL, Squazzo SL et al (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270:9564–9570CrossRefPubMed
Zurück zum Zitat Pratico D, Uryu K, Leight S et al (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183–4187PubMed Pratico D, Uryu K, Leight S et al (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183–4187PubMed
Zurück zum Zitat Reers M, Smiley ST, Mottola-Hartshorn C et al (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406–417CrossRefPubMed Reers M, Smiley ST, Mottola-Hartshorn C et al (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406–417CrossRefPubMed
Zurück zum Zitat Renkawek K, Bosman GJ, de Jong WW (1994) Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol 87:511–519CrossRefPubMed Renkawek K, Bosman GJ, de Jong WW (1994) Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol 87:511–519CrossRefPubMed
Zurück zum Zitat Renkawek K, Stege GJ, Bosman GJ (1999) Dementia, gliosis and expression of the small heat-shock proteins hsp27 and alpha B-crystallin in Parkinson’s disease. Neuroreport 10:2273–2276CrossRefPubMed Renkawek K, Stege GJ, Bosman GJ (1999) Dementia, gliosis and expression of the small heat-shock proteins hsp27 and alpha B-crystallin in Parkinson’s disease. Neuroreport 10:2273–2276CrossRefPubMed
Zurück zum Zitat Roher AE, Lowenson JD, Clarke S et al (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer’s disease. J Biol Chem 268:3072–3083PubMed Roher AE, Lowenson JD, Clarke S et al (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer’s disease. J Biol Chem 268:3072–3083PubMed
Zurück zum Zitat Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650CrossRefPubMed Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650CrossRefPubMed
Zurück zum Zitat Schipper HM, Bennett DA, Liberman A et al (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27:252–261CrossRefPubMed Schipper HM, Bennett DA, Liberman A et al (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27:252–261CrossRefPubMed
Zurück zum Zitat Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106–113CrossRefPubMed Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106–113CrossRefPubMed
Zurück zum Zitat Shoji M, Golde TE, Ghiso J et al (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126–129CrossRefPubMed Shoji M, Golde TE, Ghiso J et al (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126–129CrossRefPubMed
Zurück zum Zitat Sponne I, Fifre A, Drouet B et al (2003) Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem 278:3437–3445CrossRefPubMed Sponne I, Fifre A, Drouet B et al (2003) Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem 278:3437–3445CrossRefPubMed
Zurück zum Zitat Tamaoka A, Kondo T, Odaka A et al (1994) Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer’s disease. Biochem Biophys Res Commun 205:834–842CrossRefPubMed Tamaoka A, Kondo T, Odaka A et al (1994) Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer’s disease. Biochem Biophys Res Commun 205:834–842CrossRefPubMed
Zurück zum Zitat Tomiyama T, Asano S, Furiya Y et al (1994) Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem 269:10205–10208PubMed Tomiyama T, Asano S, Furiya Y et al (1994) Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem 269:10205–10208PubMed
Zurück zum Zitat Veereshwarayya V, Kumar P, Rosen KM et al (2006) Differential effects of mitochondrial heat-shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J Biol Chem 281:29468–29478CrossRefPubMed Veereshwarayya V, Kumar P, Rosen KM et al (2006) Differential effects of mitochondrial heat-shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J Biol Chem 281:29468–29478CrossRefPubMed
Zurück zum Zitat Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539CrossRefPubMed Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539CrossRefPubMed
Zurück zum Zitat Wang R, Sweeney D, Gandy SE et al (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem 271:31894–31902CrossRefPubMed Wang R, Sweeney D, Gandy SE et al (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem 271:31894–31902CrossRefPubMed
Zurück zum Zitat Wilhelmus MM, Otte-Holler I, Wesseling P et al (2006) Specific association of small heat-shock proteins with the pathological hallmarks of Alzheimer’s disease brains. Neuropathol Appl Neurobiol 32:119–130CrossRefPubMed Wilhelmus MM, Otte-Holler I, Wesseling P et al (2006) Specific association of small heat-shock proteins with the pathological hallmarks of Alzheimer’s disease brains. Neuropathol Appl Neurobiol 32:119–130CrossRefPubMed
Zurück zum Zitat Wilhelmus MM, de Waal RM, Verbeek MM (2007) Heat-shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer’s disease. Mol Neurobiol 35:203–216CrossRefPubMed Wilhelmus MM, de Waal RM, Verbeek MM (2007) Heat-shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer’s disease. Mol Neurobiol 35:203–216CrossRefPubMed
Zurück zum Zitat Yang T, Hsu C, Liao W et al (2008) Heat-shock protein 70 expression in epilepsy suggests stress rather than protection. Acta Neuropathol 115:219–230CrossRefPubMed Yang T, Hsu C, Liao W et al (2008) Heat-shock protein 70 expression in epilepsy suggests stress rather than protection. Acta Neuropathol 115:219–230CrossRefPubMed
Metadaten
Titel
Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons
verfasst von
Ting-Ting Yang
Chao-Tien Hsu
Yu-Min Kuo
Publikationsdatum
01.12.2009
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 12/2009
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-009-0311-0

Weitere Artikel der Ausgabe 12/2009

Journal of Neural Transmission 12/2009 Zur Ausgabe

Basic Neurosciences, Genetics and Immunology - Review Article

Glycine as a neurotransmitter in the forebrain: a short review

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.